- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03305276
Observatory on Impact of Life Styles on Health Outcomes (OIVITA)
Evaluation of the Impact of Mediterranean Lifestyle and Diet on Intermediate and Final Endpoints of Health
Study Overview
Status
Conditions
Detailed Description
In occasion of the World Hypertension Day in may , boots are organized in the major squares of the southern italy villages, and volunteers of the Medical School of Salerno collect through means of questionnaires, anamnestic data and dietary habits, and measure blood pressure after 5 minutes in the sitting position, 3 times with an interval of 2 minutes using validated, ESH approved electronic oscillometer (A100, Microlife, Italy), according to the ESC/ESH guidelines. Other questions regard previous cardiovascular conditions or events (coronary heart disease) and cardiovascular accidents (TIA and stroke). Eventual drug treatment and Vitamin D supplementation is also annotated. A venous blood sample is drawn from the antecubital vein and blood is stored for biochemical analysis at the University Hospital Centralized Service. Data are digitally stored for analysis.
Anamnestic and biochemical data regarding age, sex-specific cholesterol, HDL cholesterol, systolic BP and cigarette smoking pre-existing conditions and way of life are used for the calculation of cardiovascular risk according to the Framingham Cardiovascular Risk Score. Familiarity for cardiovascular disease is defined as cardiovascular events in parents and siblings less than 50 years old.
The validated questionnaire alternate Mediterranean Diet Score (aMed), is administered to assess adherence to the Mediterranean Diet . Laboratory assessment of blood samples. A venous blood sample was collected in two tubes of 5.0 ml and centrifuged in the day. The time of the last meal was recorded during the data collection. Blood glucose, insulin, blood urea nitrogen (BUN), creatinine, calcium, phosphorus, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, 25(OH)D, PTH, Vitamin B-12 and folic acid are assessed. Glomerular filtration rate (GFRs) is estimated using the equation of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) .
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Salerno, Italy, 84100
- Recruiting
- San Giovanni e Ruggi Hospital
-
Contact:
- Guido Iaccarino, MD
- Phone Number: 39089672335
- Email: guido.iaccarino@sangiovannieruggi.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- General population
Exclusion Criteria:
- Subjects who do not sign informed consent and do not give authorization will be excluded from the study
- Subjects fed through parenteral feeding
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
general population
the study is open to all population, (14-90 years, male/female) to verify the impact of lifestyles (mediterranean style) on intermediate and hard endpoint.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cardiovascular events
Time Frame: 10 year
|
Presence of events in the anamnesis of subjects enrolled
|
10 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cardiovascular risk
Time Frame: 10 years
|
Framingham Risk Score
|
10 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
vitamin D profile
Time Frame: 10 years
|
vitamin d serum levels will be assessed and compared to the life style
|
10 years
|
|
vitamin B12 profile
Time Frame: 10 years
|
vitamin b12 serum levels will be assessed and compared to the life style
|
10 years
|
|
Folic Acid profile
Time Frame: 10 years
|
folic acid serum levels will be assessed and compared to the life style
|
10 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1234 (Department of Defense)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Outcome
-
University Medical Center GoettingenRecruitingSupportive Care | Patient Related Outcome Measures | Patient Reported Outcome (PRO)Germany
-
Second Affiliated Hospital, School of Medicine,...Not yet recruiting
-
University of ZurichCompleted
-
Mead Johnson NutritionChulalongkorn University; Ministry of Health, ThailandNot yet recruitingOutcome Assessment
-
Lehigh Valley HospitalCompletedPregnancy OutcomeUnited States
-
Hoya Surgical Optics, Inc.Recruiting
-
Peking University Third HospitalRecruiting
-
JointResearchUppsala University; Göteborg University; Leiden University Medical Center; OLVGEnrolling by invitation
-
National Institutes of Health Clinical Center (CC)Enrolling by invitationPregnancy OutcomeUnited States
-
Danat Al Emarat HospitalActive, not recruitingOutcome MeasuresUnited Arab Emirates